Cas:307353-32-8 Methyl 3-bromo-5-(hydroxymethyl)benzoate manufacturer & supplier

We serve Chemical Name:Methyl 3-bromo-5-(hydroxymethyl)benzoate CAS:307353-32-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Methyl 3-bromo-5-(hydroxymethyl)benzoate

Chemical Name:Methyl 3-bromo-5-(hydroxymethyl)benzoate
CAS.NO:307353-32-8
Synonyms:QC-5495;3-bromo-5-hydroxymethylbenzoic acid methyl ester
Molecular Formula:C9H9BrO3
Molecular Weight:245.07000
HS Code:2918199090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:46.53000
Exact Mass:243.97400
LogP:1.72800

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like QC-5495 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-bromo-5-hydroxymethylbenzoic acid methyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-bromo-5-hydroxymethylbenzoic acid methyl ester Use and application,3-bromo-5-hydroxymethylbenzoic acid methyl ester technical grade,usp/ep/jp grade.


Related News: Britons being brought from Wuhan to the UK are being placed in quarantine at Arrowe Park Hospital in the Wirral, northwest England, Raab said. Methyl 3-bromo-5-(hydroxymethyl)benzoate manufacturer Britons being brought from Wuhan to the UK are being placed in quarantine at Arrowe Park Hospital in the Wirral, northwest England, Raab said. Methyl 3-bromo-5-(hydroxymethyl)benzoate supplier Under the strict supervision of environmental protection, it has helped the API industry to continuously optimize its product structure, realize industrial upgrading, and transition to the development of high-end APIs. Methyl 3-bromo-5-(hydroxymethyl)benzoate vendor Under the strict supervision of environmental protection, it has helped the API industry to continuously optimize its product structure, realize industrial upgrading, and transition to the development of high-end APIs. Methyl 3-bromo-5-(hydroxymethyl)benzoate factory U.S. drugmaker Gilead dominates the HIV market and it will keep up the pressure with fast-growing Biktarvy, which was approved early last year.